Most clinical reports acknowledge the job of drugs modulating by means of NMDA receptors. Ketamine is noncompetitive voltage-dependent NMDA-receptor channel blocker whose antidepressant action is apparent at very low doses, and with increasing doses, it mimics psychotomimetic action and at some point contributes to anesthesia in better doses.[4]Ket